Cobalt-Induced Ototoxicity Treated With Corticosteroids, Chelation, and Hyperbaric Oxygen Therapy

Systemic cobalt toxicity, including sensorineural hearing loss, may occur in patients with cobalt-chromium (CoCr) hip prostheses. This report describes a 45-year-old woman who underwent unilateral total hip revision surgery due to mechanical failure of her original implant. Intraoperative findings included fractures of her original ceramic prosthesis that were debrided. A new CoCr dual mobility liner and femoral head were implanted. Within a few months postoperatively, she developed sensorineural hearing loss and was diagnosed with markedly elevated plasma cobalt and chromium concentrations. She underwent a second revision procedure, but her hearing loss persisted. After treatment with prednisone, succimer, N-acetylcysteine (NAC), and hyperbaric oxygen therapy, her hearing acuity improved. For patients with arthroprosthetic cobalt toxicity, prosthesis explantation and revision are primary treatments that often result in symptom improvement, but patients who experience persistent ototoxicity may benefit from additional therapies to improve symptoms and reduce the systemic cobalt burden.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-11-17
DOI
https://doi.org/10.7759/cureus.119825
Primary Topic
Orthopaedic implants and arthroplasty
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cobalt-Induced Ototoxicity Treated With Corticosteroids, Chelation, and Hyperbaric Oxygen Therapy

Kelly K Johnson-Arbor, Hung Jeffrey Kim, Daniel Swanson
Cureus
Orthopaedic implants and arthroplasty
article

Cobalt-Induced Ototoxicity Treated With Corticosteroids, Chelation, and Hyperbaric Oxygen Therapy

Kelly K Johnson-Arbor, Hung Jeffrey Kim, Daniel Swanson
article en

Abstract

Systemic cobalt toxicity, including sensorineural hearing loss, may occur in patients with cobalt-chromium (CoCr) hip prostheses. This report describes a 45-year-old woman who underwent unilateral total hip revision surgery due to mechanical failure of her original implant. Intraoperative findings included fractures of her original ceramic prosthesis that were debrided. A new CoCr dual mobility liner and femoral head were implanted. Within a few months postoperatively, she developed sensorineural hearing loss and was diagnosed with markedly elevated plasma cobalt and chromium concentrations. She underwent a second revision procedure, but her hearing loss persisted. After treatment with prednisone, succimer, N-acetylcysteine (NAC), and hyperbaric oxygen therapy, her hearing acuity improved. For patients with arthroprosthetic cobalt toxicity, prosthesis explantation and revision are primary treatments that often result in symptom improvement, but patients who experience persistent ototoxicity may benefit from additional therapies to improve symptoms and reduce the systemic cobalt burden.

Cureus
Georgetown University (US), MedStar Georgetown University Hospital (US)
Good health and well-being
Orthopaedic implants and arthroplasty
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon